Indeed, decreased number of macrophages (CD45+ or CD68+) in the synovial sublining is the most reproducible and validated biomarker of treatment efficacy in RA, and more reliable than disease activity score 28 (DAS28) (12, 13, 22). Here, CD68 is linked to rheumatoid arthritis.